Metro Pediatrics PC
Metro Pediatrics PC was paid $4.46M by Medicaid between Jan 2018 and Dec 2024, across 88 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 37% of everything it billed.
33Billing provider infoMETRO PEDIATRICS PC
BIRMINGHAM, AL 35209
BIRMINGHAM, AL 35209
33aNPI1093855637assigned 02/06/2007
33bProvider typeSpecialist
28Total paid$4.46M
24GClaims135,867
24DCodes billed88
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Specialist providers in Alabama
Rank by total paid#6 of 162
Median peer was paid$49K
This provider vs. median90×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 11,667 | $481K | |
| 2019 | 15,232 | $554K | |
| 2020 | 17,103 | $500K | |
| 2021 | 22,513 | $643K | |
| 2022 | 33,099 | $732K | |
| 2023 | 17,853 | $733K | |
| 2024incomplete | 18,400 | $816K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 37% | 21,351 | 17,296 | $1.64M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.5% | 7,898 | 6,330 | $424K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.6% | 5,551 | 4,851 | $295K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 6.2% | 3,130 | 2,805 | $276K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.0% | 5,237 | 4,304 | $267K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.0% | 4,077 | 3,364 | $222K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4.6% | 3,799 | 3,284 | $206K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 3.6% | 813 | 767 | $161K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.1% | 961 | 838 | $95K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.8% | 9,451 | 8,104 | $80K |
| 90700 | 1.5% | 4,419 | 3,546 | $69K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.2% | 1,360 | 1,262 | $55K |
76 more codes
| 90713 | 1.1% | 3,182 | $51K | |
| 90648 | 1.1% | 3,073 | $49K | |
| 90686 | 1.1% | 2,700 | $47K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 3,943 | $42K |
| 90670 | <1% | 2,695 | $39K | |
| 90680 | <1% | 2,152 | $32K | |
| 80061 | Lipid panel | <1% | 2,418 | $29K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,721 | $27K |
| 90744 | <1% | 1,435 | $23K | |
| 90633 | <1% | 1,199 | $20K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,327 | $19K |
| 92587 | <1% | 504 | $18K | |
| 99205 | Prolong outpt/office vis | <1% | 104 | $18K |
| 90651 | <1% | 756 | $16K | |
| 90707 | <1% | 1,002 | $15K | |
| 90716 | <1% | 1,002 | $15K | |
| 94010 | <1% | 926 | $15K | |
| 96127 | <1% | 3,542 | $14K | |
| 90671 | <1% | 700 | $13K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 84 | $12K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 110 | $12K |
| 90688 | <1% | 808 | $12K | |
| 90674 | <1% | 562 | $10K | |
| 83655 | <1% | 709 | $9K | |
| 99000 | <1% | 3,841 | $9K | |
| 82947 | <1% | 2,734 | $9K | |
| Q3014 | Telehealth originating site facility fee | <1% | 481 | $8K |
| 0071A | <1% | 219 | $8K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 420 | $7K |
| 0072A | <1% | 164 | $6K | |
| 99173 | <1% | 1,343 | $6K | |
| 90621 | <1% | 358 | $5K | |
| 90734 | <1% | 292 | $5K | |
| 90661 | <1% | 190 | $4K | |
| 94664 | <1% | 645 | $4K | |
| 96160 | <1% | 2,513 | $4K | |
| 90480 | <1% | 121 | $4K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 614 | $4K |
| 90619 | <1% | 207 | $4K | |
| 90656 | <1% | 143 | $3K | |
| D1206 | Topical application of fluoride varnish | <1% | 117 | $3K |
| 96161 | <1% | 1,275 | $2K | |
| 90715 | <1% | 137 | $2K | |
| 94060 | <1% | 93 | $2K | |
| 90685 | <1% | 110 | $2K | |
| 0081A | <1% | 52 | $2K | |
| 0124A | <1% | 52 | $2K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 107 | $2K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 41 | $1K |
| D0145 | Oral evaluation for a patient under three years of age | <1% | 63 | $1K |
| 0082A | <1% | 29 | $1K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 15 | $910.00 |
| 0051A | <1% | 19 | $760.00 | |
| 92567 | <1% | 54 | $716.97 | |
| 81002 | <1% | 238 | $629.61 | |
| 90461 | <1% | 16 | $543.40 | |
| 0154A | <1% | 14 | $520.00 | |
| 90381 | <1% | 26 | $502.75 | |
| 69210 | <1% | 22 | $360.00 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 188 | $298.00 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 52 | $269.00 |
| 90380 | <1% | 12 | $178.11 | |
| 85018 | <1% | 1,004 | $152.35 | |
| 95012 | <1% | 76 | $143.00 | |
| 36416 | <1% | 3,638 | $126.95 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 79 | $15.00 |
| 99072 | 0% | 7,110 | $0.00 | |
| 99408 | 0% | 148 | $0.00 | |
| 91308 | 0% | 167 | $0.00 | |
| 97803 | 0% | 156 | $0.00 | |
| 91312 | 0% | 35 | $0.00 | |
| 91307 | 0% | 214 | $0.00 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 0% | 271 | $0.00 |
| 91305 | 0% | 114 | $0.00 | |
| 97802 | 0% | 92 | $0.00 | |
| 90647 | 0% | 45 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDAWKINS, DERROL (PRESIDENT)